Evidence map›Paper›PMID 32648950›Full record

ArticleCancer2020

Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the Pediatric Oncology East and Mediterranean (POEM) group.

Raya Saab, Anas Obeid, Fatiha Gachi, Houda Boudiaf, Lilit Sargsyan, Khulood Al-Saad, Tamar Javakhadze, Azim Mehrvar, Sawsan Sati Abbas, Yasir Saadoon Abed Al-Agele and 29 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Impact and control of the COVID pandemic in an elite sports club: Real Madrid.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Article
  12. Cobalt compensator-based IMRT device: A treatment planning study of head and neck cases.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Impact of the COVID-19 Pandemic on Melanoma Diagnosis in Romania-Data from Two University Centers.International journal of environmental research and public health · 2022
    Article
  18. How has the COVID-19 pandemic impacted clinical care and research in Neuro-Oncology?Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 20 countries.

Raya SaabChildren's Cancer Institute, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.ORCID 0000-0001-5776-2303
Anas ObeidChildren's Cancer Institute, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Fatiha GachiDepartment of Pediatrics, Pierre and Marie Curie Center, Algiers, Algeria.
Houda BoudiafDepartment of Pediatrics, Mustapha Pacha Hospital, Moustapha, Algeria.
Lilit SargsyanPediatric Cancer and Blood Disorders Center of Armenia, Professor R.H. Yeolyan Hematology Center, Yerevan, Armenia.
Khulood Al-SaadDepartment of Pediatrics, Salmaniya Medical Complex, Manama, Bahrain.
Tamar JavakhadzeDepartment of Pediatrics, Iashvili Children's Central Hospital, Tbilisi, Georgia.
Azim MehrvarMAHAK Pediatric Cancer Treatment and Research Center, Tehran, Iran.
Sawsan Sati AbbasDepartment of Pediatrics, Al-Imamian Al-Kadhimiyain Medical City, Baghdad, Iraq.
Yasir Saadoon Abed Al-AgeleDepartment of Pediatrics, Ibn al-Athir Teaching Hospital for Children, Al-Mausil, Iraq.
Salma Al-HaddadDepartment of Pediatrics, Children Welfare Teaching Hospital, Medical City, Baghdad, Iraq.
Mouroge Hashim Al AniDepartment of Pediatrics, Nanakaly Hospital for Blood Disease, Kurdistan, Iraq.
Suleiman Al-SweedanDepartment of Pediatrics, King Abdullah University Hospital, Ar Ramtha, Jordan.
Amani Al KofideDepartment of Pediatric Hematology/Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
Wasil JastaniahPrincess Noorah Oncology Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs-Western Region, Jeddah, Kingdom of Saudi Arabia.
Nisreen KhalifaNational Bank of Kuwait Children's Hospital, Kuwait City, Kuwait.
Elie BecharaDepartment of Pediatrics, Lebanese Hospital Geitaoui, Beirut, Lebanon.
Malek BaassiriDepartment of Pediatrics, Makassed General Hospital, Beirut, Lebanon.
Peter NounDepartment of Pediatrics, St George Hospital University Medical Center, Beirut, Lebanon.
Jamila El-HoudziDepartment of Pediatric Hematology-Oncology, Mohammed VI Marrakech University Hospital Center, Marrakech, Morocco.
Mohammed KhattabPediatric Hematology and Oncology Center, Ibn Sina University Hospital Center, Rabat, Morocco.
Krishna Sagar SharmaDepartment of Medical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Nepal.
Yasser WaliChild Health Department, Sultan Qaboos University Hospital, Muscat, Oman.
Naureen MushtaqDepartment of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.
Aliya BatoolPediatric Hematology Oncology and Bone Marrow Transplant Unit, Dr. Akbar Niazi Teaching Hospital, Islamabad, Pakistan.
Mahwish FaizanDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplant, The Children's Hospital and the Institute of Child Health, Lahore, Pakistan.
Muhammad Rafie RazaDepartment of Pediatric Oncology, The Indus Hospital, Karachi, Pakistan.
Mohammad NajajrehHuda Al Masri Pediatric Cancer Department, Beit Jala Governmental Hospital, Beit Jala, Palestine.
Mohammed Awad Mohammed AbdallahDepartment of Pediatrics, Khartoum Oncology Hospital, Khartoum, Sudan.
Ghada SousanDepartment of Pediatrics, Al Bairouni Hospital, Damascus, Syria.
Khaled M GhanemBasma Pediatric Oncology Unit, Al Bairouni Hospital, Damascus, Syria.
Ulker KocakDepartment of Pediatrics, Gazi University Hospital, Ankara, Turkey.
Tezer KutlukDepartment of Pediatric Oncology, Hacettepe University Cancer Institute and Faculty of Medicine, Ankara, Turkey.
Hacı Ahmet DemirDepartment of Pediatric Hematology-Oncology, Private Memorial Ankara Hospital, Ankara, Turkey.
Hamoud HodeishPediatric Oncology Department, National Oncology Center, Sana'a, Yemen.
Samar MuwakkitChildren's Cancer Institute, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Asim BelgaumiDepartment of Pediatrics, Aga Khan University Hospital, Karachi, Pakistan.
Abdul-Hakim Al-RawasChild Health Department, Sultan Qaboos University Hospital, Muscat, Oman.
Sima JehaDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
American University of Beirut Medical Center · LBAga Khan University Hospital · PKBaghdad Medical City · IQDamascus Hospital · SYSultan Qaboos University Hospital · OMAlsalam University College · IQB.P. Koirala Memorial Cancer Hospital · NPCenter of Medical Genetics and Primary Health Care · AMCentral State Hospital · USCentre Hospitalier Universitaire Mohammed VI · MAGazi University · TRHacettepe University Hospital · TRHôpital Ibn Sina-Rabat · MAHôpital Mustapha Pacha · DZIbn Sina Hospital · KWIndus Hospital · PKKing Abdullah University Hospital · JOKing Faisal Specialist Hospital & Research Centre · SAKurdistan Regional Government · IQLebanese Hospital Geitaoui-University Medical Center · LB

Funding

American Lebanese Syrian Associated Charities
6 · The paper itself

Abstract

backgroundChildhood cancer is a highly curable disease when timely diagnosis and appropriate therapy are provided. A negative impact of the coronavirus disease 2019 (COVID-19) pandemic on access to care for children with cancer is likely but has not been evaluated.

methodsA 34-item survey focusing on barriers to pediatric oncology management during the COVID-19 pandemic was distributed to heads of pediatric oncology units within the Pediatric Oncology East and Mediterranean (POEM) collaborative group, from the Middle East, North Africa, and West Asia. Responses were collected on April 11 through 22, 2020. Corresponding rates of proven COVID-19 cases and deaths were retrieved from the World Health Organization database.

resultsIn total, 34 centers from 19 countries participated. Almost all centers applied guidelines to optimize resource utilization and safety, including delaying off-treatment visits, rotating and reducing staff, and implementing social distancing, hand hygiene measures, and personal protective equipment use. Essential treatments, including chemotherapy, surgery, and radiation therapy, were delayed in 29% to 44% of centers, and 24% of centers restricted acceptance of new patients. Clinical care delivery was reported as negatively affected in 28% of centers. Greater than 70% of centers reported shortages in blood products, and 47% to 62% reported interruptions in surgery and radiation as well as medication shortages. However, bed availability was affected in <30% of centers, reflecting the low rates of COVID-19 hospitalizations in the corresponding countries at the time of the survey.

conclusionsMechanisms to approach childhood cancer treatment delivery during crises need to be re-evaluated, because treatment interruptions and delays are expected to affect patient outcomes in this otherwise largely curable disease.

Indexed as

COVID-19Africa, NorthernAsia, WesternChildCross-Sectional StudiesDelivery of Health CareHealth PersonnelHospitalsHumansMiddle EastNeoplasmsSurveys and Questionnairescare deliverycoronavirus disease 2019 (COVID-19)middle-income countriespandemicpediatric oncology

Identifiers

PMID32648950
PMCPMC7404449
OpenAlexW3042041468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.